Filing Details
- Accession Number:
- 0001719842-18-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-02 16:31:53
- Reporting Period:
- 2018-08-02
- Accepted Time:
- 2018-08-02 16:31:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1710155 | National Vision Holdings Inc. | EYE | Ophthalmic Goods (3851) | 464841717 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1719842 | John Vaught | C/O National Vision Holdings, Inc. 2435 Commerce Avenue, Bldg. 2200 Duluth GA 30096-4980 | Svp, Chief Information Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-08-02 | 2,164 | $38.26 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-08-02 | 5,035 | $4.27 | 5,035 | $4.27 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
53,705 | 2024-03-13 | No | 4 | A | Direct |
Footnotes
- This amount represents the secondary public offering price per share of common stock of National Vision Holdings, Inc., less the underwriting discount of $1.4906 per share, in connection with the exercise of the underwriters' over-allotment option.
- On March 13, 2014, the reporting person was granted stock options, subject to time-based and performance-based vesting. On August 2, 2018, a liquidity event with respect to such performance-based stock options occurred as a result of sales by the Issuer's sponsor stockholders and 5,035 stock options which had previously not been reported were deemed earned.
- Of the 53,705 stock options reported herein, 40,279 are vested and the remaining 13,428 time-based stock options will vest March 13, 2019. An additional 60,419 stock options which remain subject to liquidity-event performance-based vesting conditions are not included in the table above.